Curasept Afterapid
CURASEPT SpA · source
MOUTH ULCERS: A TROUBLESOME ISSUE
Aphthous ulcers are the most common lesions of the oral mucosa, and in 80% of cases the first aphthous ulcer appears before the age of 30. The prevalence of this problem can affect up to 60% of the population. It is estimated that in one-fifth of cases, episodes are frequent and repeated over the years.
PREDISPOSING FACTORS
- Nutritional deficiencies
- Systemic diseases
- Psychological conditions
- Mucosal injuries
- Genetic predisposition
- Allergies and intolerances
THE SYMPTOMS
- Spontaneous pain and burning at phonation.
- Swelling and pain in nearby lymph nodes.
- Increased salivation.
- Difficulty and pain in chewing with possible loss of appetite.
- Difficulty and pain with oral hygiene maneuvers.
- Diagnosis is mainly based on clinical appearance and medical history.
THE AFTERAPID FORMULATION
It's a comprehensive and innovative formulation based on the emulsion of MUCOADESIVE POLYMERS ENRICHED WITH ACTIVE PARTICLES that protect the wound, provide relief and accelerate healing.
DNA/RNA
STIMULATES BIOLOGICAL MECHANISMS OF TISSUE REPAIR
BIOMOIST® HYALURONIC ACID
FILM-FORMING AND MOISTURIZING POWER
TEA TREE OIL AND MANUKA OIL
ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY
18ß GLYCIRRETIC ACID
ANTI-INFLAMMATORY FUNCTION
RUSCOGENIN
ASTRINGENT ACTIVITY
ALLANTOIN
CELL PROLIFERATION
QUICK RELIEF, QUICK RECOVERY
Forms a lipid-protective film on the wound.
Product Information
| Manufacturer | CURASEPT SpA |
|---|